Statins and autonomic function in chronic heart failure

Cardiovascular Drugs and Therapy

Volumn 19, Issue 3, 2005, Pages 167-168

  Van Der Harst, Pim ^a   Voors, Adriaan A ^a   Van Gilst, Wiek H ^a   Van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN; SIMVASTATIN;

CONGESTIVE CARDIOMYOPATHY; EDITORIAL; FOURIER TRANSFORMATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; M MODE ECHOCARDIOGRAPHY; MEDICAL LITERATURE; MEDICAL RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZATION; REDUCTION;

AUTONOMIC NERVOUS SYSTEM; CHRONIC DISEASE; HEART FAILURE, CONGESTIVE; HEART RATE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PYRROLES;

EID: 24344474485     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-005-2766-z     Document Type: Editorial

References (17)

1. Krum H, McMurray JJ. Statins and chronic heart failure: Do we need a large-scale outcome trial? J Am Coll Cardiol 2002;39:1567-1573.
2. Bohm M, Hjalmarson A, Kjekshus J, Laufs U, McMurray J, van Veldhuisen DJ. Heart failure and statins-Why do we need a clinical trial? Z Kardiol 2005;94:223-230.
3. Node K, Fujita M, Kitakaze M, Hori M, Liao JK. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 2003;108:839-843.
4. Laufs U, Wassmann S, Schackmann S, Heeschen C, Bohm M, Nickenig G. Beneficial effects of statins in patients with non-ischemic heart failure. Z Kardiol 2004;93:103-108.
5. Tousoulis D, Antoniades C, Bosinakou E, et al. Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure. Heart 2005;91:27-31.
6. Tousoulis D, Antoniades C, Bosinakou E, et al. Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure. Atherosclerosis 2005;178:359-363.
7. Dunselman P, Hjalmarson A, Kjekshus J, McMurray J, Waagstein F. The statin wars. Lancet 2003;362:1854.
8. Tavazzi L, Tognoni G, Franzosi MG, et al. On behalf of the GISSI-HF investigators. Rationale and design of the GISSI heart failure trial: A large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail 2004;6:635-641.
9. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220-222.
10. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996;17:354-381.
11. Brouwer J, van Veldhuisen DJ, Man in't Veld AJ, et al. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group. J Am Coll Cardiol 1996;28:1183-1189.
12. Bonaduce D, Petretta M, Marciano F, et al. Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure. Am Heart J 1999;138:273-284.
13. Hamaad A, Sosin M, Lip GY, MacFadyen RJ. Short term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure. Cardiovasc Drugs Ther 2005.
14. Pelat M, Dessy C, Massion P, Desager JP, Feron O, Balligand JL. Rosuvastatin Decreases Caveolin-1 and Improves Nitric Oxide-Dependent Heart Rate and Blood Pressure Variability in Apolipoprotein E-/- Mice In Vivo. Circulation 2003;107:2480.
15. Pliquett RU, Cornish KG, Peuler JD, Zucker IH. Simvastatin Normalizes Autonomic Neural Control in Experimental Heart Failure. Circulation 2003;107:2493.
16. Pliquett RU, Cornish KG, Zucker IH. Statin therapy restores sympathovagal balance in experimental heart failure. J Appl Physiol 2003;95:700-704.
17. van der Harst P, Wagenaar LJ, Buikema H, et al. Short-term atorvastatin treatment improves vasomotor function in a dose-dependent manner in internal thoracic arteries of coronary bypass surgery patients. J Am Coll Cardiol 2005;45: 438A.